课题基金 / 基金详情

Imaging Biomarkers to Characterize Emphysema Progression: Evidence and Endpoints for the Development of Matrix Metalloproteinase-12 Inhibitors

Imaging Biomarkers to Characterize Emphysema Progression: Evidence and Endpoints for the Development of Matrix Metalloproteinase-12 Inhibitors
通过成像生物标志物来表征肺气肿进展：基质金属蛋白酶 12 抑制剂开发的证据和终点
批准号：
466577
负责人：
Thakar Ashutosh
金额：
$1.27万
依托单位：
McMaster University
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-12-01 至 2022-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=466577&lang=en
关键词：
Chronic Obstructive Pulmonary Disease (Copd) Computed Tomography Cytokines And Chemokines Disease Progression Emphysema Hyperpolarized Magnetic Resonance Imaging Imaging Biomarkers Of Copd Lung Inflammation Matrix Metalloproteinase-12 Sputum And

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Chronic obstructive pulmonary disease (COPD) affects our lungs and is a leading cause of hospital admission and death in Canada. COPD is caused by chronic exposure to toxic air pollutants and cigarette smoke, that lead to the release of inflammatory chemi
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金